longevitywatch
HomeHormone
Hormone

GLP-1

Also: glp1, glp-1 agonist, glp-1 receptor agonist
Last scientific update: jun 2026

GLP-1 (glucagon-like peptide-1) is a gut hormone that stimulates insulin release, curbs appetite and slows stomach emptying. Medicines that mimic it, such as semaglutide and tirzepatide, are used for diabetes and obesity.

GLP-1 at a glance

WorksYes, for weight lossStrong
PossiblyHealthier agingPreliminary
SafeYes, under supervisionModerate
FormWeekly injection or pill

GLP-1 medicines such as semaglutide and tirzepatide are the most effective options so far for weight loss in obesity.

33 studies5 answersupdated jun 2026
Evidence per claim
Helps with substantial weight loss in obesity
View evidence →
Strong
Improves blood pressure and cholesterol through weight loss
View evidence →
Moderate
Helps you age more healthily
View evidence →
Preliminary
Lowers blood sugar in type 2 diabetes
Strong
Practical use

For whom

People with overweight or obesity, and people with type 2 diabetes, by prescription and under a doctor supervision.

Not for whom

Not meant for cosmetic weight loss without a medical reason. Be cautious with severe gastrointestinal problems or a history of pancreatitis; consult your doctor.

Usual dose

Weekly injection (semaglutide, tirzepatide) or a daily pill, at an increasing dose. Always by prescription.

Key caveats

Works while you take it; weight often returns after stopping. Side effects are mainly nausea and gut complaints. Combine with diet and exercise to preserve muscle mass.

What we know, and don't

Known

Produces substantial weight loss and better blood sugar
Lowers cardiovascular risk in high-risk people
Works while you take it

Not yet

The effects over many years
Whether it extends the lifespan of healthy people
How best to keep weight off after stopping
Common misconceptions
"GLP-1 is an easy way out."
False. Obesity is a medical condition; weight loss lowers real health risk.Moderate evidence
"You can stop right after losing weight."
False. Weight often returns after stopping; it is a long-term treatment.Strong evidence
"It only works on appetite."
Incomplete. It also improves blood sugar and possibly cardiovascular risk.Moderate evidence
How GLP-1 connects
Related news
GLP-1 drugs are reshaping health spendingGLP-1 drugs: who wins the market race?GLP-1 drug measurably slows biological aging
Data sources

Wikidata Q424611 · MeSH D052216

Newsletter

Stay in the loop

Every two weeks, the most notable longevity research in your inbox. No hype.